Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

in 40 preclinical abstracts presented at scientific congresses, and 15 original peer-reviewed scientific manuscripts in leading scientific journals, plus 17 review articles and commentaries in the literature. Most recently 8 presentations were made at the American Association for Cancer Research in April, where ibrutinib was evaluated preclinically in various disease settings.

Today over 1300 patients have been dosed with ibrutinib in company sponsored trials. Together with our collaboration partner Janssen, Pharmacyclics has engaged upwards of approximately 250 clinical sites, using ibrutinib in CLL, and additionally over 100 clinical sites engaged for the use of ibrutinib in MCL. These numbers are continuously growing as new studies are being initiated within the overall clinical development program. As of today there are over 28 studies registered with the U.S. National Institutes of Health. Five of these studies are Phase III trials, which each enrolling approximately 300-600 patients. Several of the trials in our clinical program are sponsored by the National Cancer Institute or other medical centers. To date ibrutinib is being clinically advanced in over 25 countries, which include the major population regions: U.S., Europe, Asia Pacific and Latin America.

Phase II / III / IV Clinical Trials Initiated with Ibrutinib Over the Last 12 Months

  • A multicenter, open label Expanded Access Program for ibrutinib in R/R MCL patients (MCL4001) is being initiated in the US by Janssen. In the time before a potential U.S. marketing approval, Pharmacyclics and Janssen will strive to provide early access to ibrutinib under an Expanded Access Program (EAP). EAPs are clinical studies allowed under certain circumstances by the FDA. They are designed to provide a mechanism for access to an investigational drug to treat patients with a serious or immediately life-threatening diseases or conditions until the time of an anticipated U.S. marketing approval. Fur
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
    9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
    10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
    11. Hospira Reports First-Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/14/2014)... 2014  Remedy Informatics, the leading provider of ... life sciences research, announced that it has teamed ... build the first-ever national patient registry devoted to ... "The National Pancreas Foundation is a ... and committed organizations can effect upon society as ...
    (Date:7/14/2014)... 14, 2014  GenSpera, Inc. (OTCQB: GNSZ), a ... of cancer, announces that Kareg Corporation,s Director of ... the following research report on  the company. ... of Research, Kareg Corporation, Initiating Coverage with a ... full report: http://www.genspera.com/press/140711_Genspera_research_report_July2014.pdf GNSZ ...
    (Date:7/14/2014)... -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the ... disorders of the inner and middle ear, today announced ... Form S-1 with the U.S. Securities and Exchange Commission ... shares of its common stock. All shares of common ... offered by Otonomy. The number of shares to be ...
    Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 2Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 4Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 5Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 6Otonomy Files Registration Statement for Proposed Initial Public Offering 2
    ... artery that feeds the heart, the body responds by ... As these so-called collateral,vessels grow more muscular and interconnected, ... the blockage. Scientists have been trying for,years to nudge ... success. However, you can do it at home without ...
    ... RenalGuard(TM) in preventing ... Contrast -Induced Nephropathy, FRANKLIN, Mass., Dec. ... focused on innovative cardiac and vascular medical,device-based technologies, announced today ... trial of its RenalGuard Therapy(TM).,The lead investigators are Charles Davidson, ...
    Cached Medicine Technology:Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes 2PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 2PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 3PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 4
    (Date:7/14/2014)... Barbara Bronson Gray HealthDay ... -- New research suggests that a faltering sense of ... and that an inexpensive, low-tech smell test could spot ... two different studies, the decreased ability to identify odors ... and progression to Alzheimer,s disease. "We,re trying to ...
    (Date:7/14/2014)... By Kathleen Doheny ... -- Losing a spouse may be linked to multiple health ... new study. For certain seniors, widowhood may even delay ... mild memory problem, losing the spouse was associated with a ... stayed married," said study researcher Dr. Bryan Woodruff. ...
    (Date:7/14/2014)... Greenwich, Connecticut (PRWEB) July 14, 2014 ... Medic is celebrating its Grand Opening on Monday, ... Greenwich, Connecticut 06830. The celebration will last all ... for all new patients. Everyone is welcomed to ... Soika, M.D. who provides physician-administered skincare, anti-aging, weight ...
    (Date:7/14/2014)... (PRWEB) July 14, 2014 Many people ... people undergo plastic surgery to reduce a “double chin.” ... however, eliminates the need to go under the knife. ... works the jaw muscles, therefore tightening the skin in ... chins. , Jawflex is used for facial exercise, double ...
    (Date:7/14/2014)... July 14, 2014 Since 1986, the ... icon to the Tysons Corner skyline and a staple ... own municipality, known simply as “Tysons”, the iconic hotel ... In addition to Tysons becoming its own municipality, ... the heart of Tysons brings an evolution of great ...
    Breaking Medicine News(10 mins):Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 3Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 4
    ... Study finds fewer complications with electrophysiologists , , TUESDAY, April ... of electrophysiology, but it,s a medical subspecialty you should ... or so Americans who will have a heart defibrillator ... when needed to keep an aberrant heart beating regularly. ...
    ... 21 DaVita Inc. (NYSE: DVA ... for those diagnosed with chronic kidney disease (CKD), ... the company,s Senior Vice President of Federal Legislative ... policy efforts in Washington, D.C. and report to ...
    ... April 21 New research with actionable insights on ... is now available in the Best Practice Database, an ... Best Practices, LLC.To review key topics in these studies, ... of the two new studies at this address: ...
    ... NASA,s newest piece of astronaut fitness gear headed for the ... that wants to avoid too many house calls for repairs. ... without a belt change."The COLBERT represents the integrated efforts of ... and very critical piece of flight hardware," said Jim Kukla, ...
    ... 21 On Wednesday, April 22, 2009 GlaxoSmithKline plc (NYSE: ... results for the three months ended March 31, 2009. ... the London Stock Exchange at approximately 7:00 AM EDT.At ... Julian Heslop, Chief Financial Officer will hold a briefing meeting ...
    ... an object to see it better, they lose the wide-angle ... context for detail. But now an imaging method developed by ... of the scene at once in the same high detail. ... other optical devices. , "It allows you to take ...
    Cached Medicine News:Health News:Doctor's Training Affects Defibrillator Implant Results 2Health News:Doctor's Training Affects Defibrillator Implant Results 3Health News:John Schaeffler Appointed Senior Vice President for Federal Legislative Affairs 2Health News:Best Practice Database Adds Research Highlighting Effective Data Gathering Approaches for Competitive Intelligence and Successful Activities for Gaining Maximum Payer Access and Insights 2Health News:NASA's 'COLBERT' Supplied by Wyle is Designed to Minimize House Calls 2Health News:New technique that scrambles light may lead to sharper images, wider views 2Health News:New technique that scrambles light may lead to sharper images, wider views 3Health News:New technique that scrambles light may lead to sharper images, wider views 4
    The Needle Loading Shield protects the head and torso during the needle loading process. The slim design allows the technician to load needles with both hands while looking through the lead glass....
    The vertical needle holder conveniently positions 20 needles vertically in numbered positions for easy loading....
    ... prostate seeding needles for use ... quality, disposable needles used to ... procedures. Each needle has an ... insertion, and an echogenic tip ...
    MT-BT-5001-25 prostate seeding needle (set of 25 unloaded needles).,MT-BT-5001-P prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seeding...
    Medicine Products: